These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 31975573)
41. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Dar P; Curnow KJ; Gross SJ; Hall MP; Stosic M; Demko Z; Zimmermann B; Hill M; Sigurjonsson S; Ryan A; Banjevic M; Kolacki PL; Koch SW; Strom CM; Rabinowitz M; Benn P Am J Obstet Gynecol; 2014 Nov; 211(5):527.e1-527.e17. PubMed ID: 25111587 [TBL] [Abstract][Full Text] [Related]
42. [CLINICAL IMPLEMENTATION OF CELL-FREE DNA ANALYSIS IN MATERNAL BLOOD IN SCREENING FOR ANEUPLOIDIES IN SINGLETON PREGNANCIES]. Chaveeva P; Yankova M; Stratieva V; Dimitrov I; Shterev A Akush Ginekol (Sofiia); 2016; 55(2):10-5. PubMed ID: 27509651 [TBL] [Abstract][Full Text] [Related]
43. Performance of semiconductor sequencing platform for non-invasive prenatal genetic screening for fetal aneuploidy: results from a multicenter prospective cohort study in a clinical setting. El Khattabi LA; Brun S; Gueguen P; Chatron N; Guichoux E; Schutz S; Nectoux J; Sorlin A; Quere M; Boudjarane J; Tsatsaris V; Mandelbrot L; Schluth-Bolard C; Dupont JM; Rooryck C; Ultrasound Obstet Gynecol; 2019 Aug; 54(2):246-254. PubMed ID: 30191619 [TBL] [Abstract][Full Text] [Related]
44. Aneuploidy: the impact of chromosome imbalance on nuclear organization and overall genome expression. Hervé B; Coussement A; Gilbert T; Dumont F; Jacques S; Cuisset L; Chicard M; Hizem S; Bourdoncle P; Letourneur F; Dupont C; Vialard F; Choiset A; Dupont JM Clin Genet; 2016 Jul; 90(1):35-48. PubMed ID: 27283765 [TBL] [Abstract][Full Text] [Related]
45. Prenatal diagnosis of trisomy 21, 18 and 13 by quantitative pyrosequencing of segmental duplications. Tong H; Jin Y; Xu Y; Zou B; Ye H; Wu H; Kumar S; Pitman JL; Zhou G; Song Q Clin Genet; 2016 Nov; 90(5):451-455. PubMed ID: 26948280 [TBL] [Abstract][Full Text] [Related]
46. Clinical evaluation of the IONA test: a non-invasive prenatal screening test for trisomies 21, 18 and 13. Papageorghiou AT; Khalil A; Forman M; Hulme R; Mazey R; Mousa HA; Johnstone ED; McKelvey A; Cohen KE; Risley M; Denman W; Kelly B Ultrasound Obstet Gynecol; 2016 Feb; 47(2):188-93. PubMed ID: 26493543 [TBL] [Abstract][Full Text] [Related]
47. The Combining Effects of Cell-Free Circulating Tumor DNA of Breast Tumor to the Noninvasive Prenatal Testing Results: A Simulating Investigation. Cai YH; Yao GY; Chen LJ; Gan HY; Ye CS; Yang XX DNA Cell Biol; 2018 Jul; 37(7):626-633. PubMed ID: 29957029 [TBL] [Abstract][Full Text] [Related]
48. Commentary: Cardiac surgery in children with trisomy 13 and trisomy 18: "Is it the quality of life or the quantity?". Kavarana MN J Thorac Cardiovasc Surg; 2021 Jul; 162(1):251-252. PubMed ID: 33618888 [No Abstract] [Full Text] [Related]
49. Cost and efficacy comparison of prenatal recall and reflex DNA screening for trisomy 21, 18 and 13. Bestwick JP; Wald NJ PLoS One; 2019; 14(7):e0220053. PubMed ID: 31344071 [TBL] [Abstract][Full Text] [Related]
50. First-trimester screening for trisomies 18 and 13, triploidy and Turner syndrome by detailed early anomaly scan. Wagner P; Sonek J; Hoopmann M; Abele H; Kagan KO Ultrasound Obstet Gynecol; 2016 Oct; 48(4):446-451. PubMed ID: 26611869 [TBL] [Abstract][Full Text] [Related]
51. Cell-Free DNA Analysis of Targeted Genomic Regions in Maternal Plasma for Non-Invasive Prenatal Testing of Trisomy 21, Trisomy 18, Trisomy 13, and Fetal Sex. Koumbaris G; Kypri E; Tsangaras K; Achilleos A; Mina P; Neofytou M; Velissariou V; Christopoulou G; Kallikas I; González-Liñán A; Benusiene E; Latos-Bielenska A; Marek P; Santana A; Nagy N; Széll M; Laudanski P; Papageorgiou EA; Ioannides M; Patsalis PC Clin Chem; 2016 Jun; 62(6):848-55. PubMed ID: 27117469 [TBL] [Abstract][Full Text] [Related]
52. Mortality and Resource Use Following Cardiac Interventions in Children with Trisomy 13 and Trisomy 18 and Congenital Heart Disease. Domingo L; Carey JC; Eckhauser A; Wilkes J; Menon SC Pediatr Cardiol; 2019 Feb; 40(2):349-356. PubMed ID: 30291384 [TBL] [Abstract][Full Text] [Related]
53. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result. Revello R; Sarno L; Ispas A; Akolekar R; Nicolaides KH Ultrasound Obstet Gynecol; 2016 Jun; 47(6):698-704. PubMed ID: 26743020 [TBL] [Abstract][Full Text] [Related]
54. Additive Diagnostic Yield of Homozygosity Regions Identified During Chromosomal microarray Testing in Children with Developmental Delay, Dysmorphic Features or Congenital Anomalies. Ali MAM; Hassan AM; Saafan MA; Abdelmagid AA Biochem Genet; 2020 Feb; 58(1):74-101. PubMed ID: 31273557 [TBL] [Abstract][Full Text] [Related]
55. Perspectives on the care and advances in the management of children with trisomy 13 and 18. Carey JC; Kosho T Am J Med Genet C Semin Med Genet; 2016 Sep; 172(3):249-50. PubMed ID: 27643592 [TBL] [Abstract][Full Text] [Related]
56. Trisomy 18 and trisomy 21 mosaicism in a Down's syndrome patient. Thomas IM; Sayee R; Shavanthi L; Sridevi H J Med Genet; 1994 May; 31(5):418-9. PubMed ID: 8064824 [TBL] [Abstract][Full Text] [Related]
57. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Gil MM; Quezada MS; Revello R; Akolekar R; Nicolaides KH Ultrasound Obstet Gynecol; 2015 Mar; 45(3):249-66. PubMed ID: 25639627 [TBL] [Abstract][Full Text] [Related]
58. Re: Low-molecular-weight heparin associated with reduced fetal fraction and subsequent false- negative cell-free DNA test result for trisomy 21. Dabi Y; Costa JM; Benachi A Ultrasound Obstet Gynecol; 2018 Feb; 51(2):278. PubMed ID: 29417678 [No Abstract] [Full Text] [Related]